Our Focus

Avecia's Biologics business is one of the world's leading contract development and manufacturers of biologics for human healthcare products.

From our base in the Tees Valley, in the UK, we have grown rapidly over the last five years, and invested over US$150m in state-of-the-art manufacturing facilities.

Our track record of meeting customer expectations is founded upon:

• technical and functional excellence
• dedicated project team focus
• a commitment to quality and cGMP compliance

pAVEway™ Advanced Protein Expression

Avecia Biologics launches its new biotherapeutic protein production technology - pAVEway™. The new technology enables class-leading (>10g/L) microbial production of a wide range of therapeutically useful proteins (vaccines, cytokines, growth factors, etc). Click here for more information.